Search Clinical Trials
598,193 trials
ID
Status
Phase
Title
Sponsor
NCT07762495
Echocardiographic Molecular Imaging for POC Detection of IschemiaNational Heart, Lung, and Blood Institute (NHLBI)Not Yet RecruitingEarly Phase 1
NCT07762495Not Yet Recruiting
Early Phase 1
Echocardiographic Molecular Imaging for POC Detection of IschemiaNational Heart, Lung, and...
NCT07762170
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Iliac Pain (CORTisone Injection Spine Study)Igor Wilderman. MDRecruitingPhase 4
NCT07762170Recruiting
Phase 4
Success Rates and Safety of Steroid Injections in Managing Spinal and Sacro-Ilia...Igor Wilderman. MD
NCT07763522
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Assessment to Quantify LDH-induced ParesisHelsinki University Central HospitalEnrolling By InvitationNot Applicable
NCT07763522Enrolling By Invitation
Not Applicable
Validation of a Methodology Using Isometric Dynamometer for Ankle STrength Asses...Helsinki University Centr...
NCT07762378
Clinical Impact of a Machine Learning Decision Support System for Empirical Antibiotic TherapyInstituto de Investigación Sanitaria Gregorio MarañónNot Yet RecruitingNot Applicable
NCT07762378Not Yet Recruiting
Not Applicable
Clinical Impact of a Machine Learning Decision Support System for Empirical Anti...Instituto de Investigació...
NCT07762209
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health ResearchNot Yet RecruitingNot Applicable
NCT07762209Not Yet Recruiting
Not Applicable
Papilozumib Vaginal Gel for Exocervical Mucosal Restoration in Women With HPVAdknoma Health Research
NCT07763171
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-negative and PD-L1 TAP Score of 5 or More Advanced Gastroesophageal AdenocarcinomaGruppo Oncologico del Nord-OvestNot Yet RecruitingPhase 3
NCT07763171Not Yet Recruiting
Phase 3
Paclitaxel, Ramucirumab and Tislelizumab Switch Maintenance in Advanced HER2-neg...Gruppo Oncologico del Nor...
NCT07762989
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longus Tendon AutograftGazi UniversityNot Yet Recruiting
NCT07762989Not Yet Recruiting
—
Donor Ankle Sensorimotor Recovery After ACL Reconstruction With a Peroneus Longu...Gazi University
NCT07762560
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter Monitoring Versus Standard Care in Heart Attack-Related Cardiogenic ShockBoston Scientific CorporationNot Yet RecruitingNot Applicable
NCT07762560Not Yet Recruiting
Not Applicable
Routine Microaxial Heart Pump Support and Protocolized Pulmonary Artery Catheter...Boston Scientific Corpora...
NCT07762430
Food Noise Survey Development and Validation in Hindi and English-Speaking AdultsDiabetes Foundation, IndiaNot Yet Recruiting
NCT07762430Not Yet Recruiting
—
Food Noise Survey Development and Validation in Hindi and English-Speaking Adult...Diabetes Foundation, Indi...
NCT07763951
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitagliptin/Metformin in Prolonged-release Tablets With 100 mg/1000 mg in Healthy Subjects, Fast Study.ADIUMCompletedNot Applicable
NCT07763951Completed
Not Applicable
Clinical Study to Determine Bioequivalence Between Two Oral Medications of Sitag...ADIUM
NCT07762950
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic PancreatitisChanghai HospitalNot Yet Recruiting
NCT07762950Not Yet Recruiting
—
Blood Biomarkers and Gut Microbiota for Pancreatic Cancer Risk in Chronic Pancre...Changhai Hospital
NCT07763938
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relapsed/Refractory B-cell MalignanciesNanjing Legend Biotech Co.Not Yet RecruitingPhase 1
NCT07763938Not Yet Recruiting
Phase 1
CD19/CD20 Dual-Target in Vivo CAR-T Lentiviral Product in the Treatment of Relap...Nanjing Legend Biotech Co...
NCT07762755
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen HospitalNot Yet RecruitingPhase 4
NCT07762755Not Yet Recruiting
Phase 4
Icosapent Ethyl for High-Risk Coronary Plaques Assessed by 18F-NaF PET/CTBeijing Anzhen Hospital
NCT07762625
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestational Diabetes MellitusCentral South UniversityNot Yet RecruitingNot Applicable
NCT07762625Not Yet Recruiting
Not Applicable
Couple-Coordinated Lifestyle Intervention for Women With a History of Gestationa...Central South University
NCT07763314
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Cancer in Switzerland Between 2003 and 2022Cantonal Hospital of St. GallenCompleted
NCT07763314Completed
—
Trends and Short-term Outcomes of Surgically Resected Early-onset Colorectal Can...Cantonal Hospital of St....
NCT07762807
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS Foundation TrustRecruitingNot Applicable
NCT07762807Recruiting
Not Applicable
Colchicine And Dialysis Patients; a Feasibility StudyGuy's and St Thomas' NHS...
NCT07761962
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversible PulpitisKing Abdullah University HospitalActive Not RecruitingNot Applicable
NCT07761962Active Not Recruiting
Not Applicable
Laser Assisted Pulpotomy Versus MTA Pulpotomy in Permanent Teeth With Irreversib...King Abdullah University...
NCT07763418
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participants With Severe Renal Impairment and End-Stage Renal Disease Compared With Participants With Normal Renal FunctionBristol-Myers SquibbNot Yet RecruitingPhase 1
NCT07763418Not Yet Recruiting
Phase 1
A Study to Evaluate the Pharmacokinetics and Safety of Golcadomide in Participan...Bristol-Myers Squibb
NCT07763847
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Contraceptive Pill.Mst.Sumyara KhatunCompletedNot Applicable
NCT07763847Completed
Not Applicable
Effect of Elagolix in Symptomatic Endometrioma in Comparison to Combined Oral Co...Mst.Sumyara Khatun
Result Breakdown
Not yet recruiting13 (65%)
Completed3 (15%)
Recruiting2 (10%)
Enrolling by invitation1 (5%)
Active, not recruiting1 (5%)
not_applicable10 (50%)
Not Specified4 (20%)
Phase 42 (10%)
Phase 12 (10%)
Early Phase 11 (5%)
Phase 31 (5%)